Approval for a modification from the existing over-the-wire delivery system to a rapid exchange delivery system for the device.  The device, as modified, will be marketed under the trade name zilver vascular stent with rapid exchange delivery system and is indicated for use as an adjunct to percutaneous transluminal angioplasty (pta) in the treatment of symptomatic vascular disease of the iliac arteries up to 100 mm in length, with a reference vessel diameter of 5 to 9 mm.  Patients must be suitable for pta and stent treatment.